Ken Fisher’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.9M | Buy |
31,158
+5,940
| +24% | +$2.77M | ﹤0.01% | 360 |
|
|
2025
Q4 | $11.4M | Sell |
25,218
-741
| -3% | -$319K | ﹤0.01% | 385 |
|
|
2025
Q3 | $10.2M | Buy |
25,959
+204
| +0.8% | +$85.3K | ﹤0.01% | 406 |
|
|
2025
Q2 | $11.5M | Sell |
25,755
-4,914
| -16% | -$2.26M | ﹤0.01% | 392 |
|
|
2025
Q1 | $14.9M | Buy |
30,669
+761
| +3% | +$355K | 0.01% | 359 |
|
|
2024
Q4 | $12M | Buy |
29,908
+2,886
| +11% | +$1.34M | ﹤0.01% | 411 |
|
|
2024
Q3 | $12.6M | Sell |
27,022
-1,083
| -4% | -$520K | 0.01% | 392 |
|
|
2024
Q2 | $13.2M | Buy |
28,105
+582
| +2% | +$253K | 0.01% | 391 |
|
|
2024
Q1 | $11.5M | Buy |
27,523
+843
| +3% | +$356K | 0.01% | 402 |
|
|
2023
Q4 | $10.9M | Buy |
26,680
+334
| +1% | +$123K | 0.01% | 398 |
|
|
2023
Q3 | $9.16M | Sell |
26,346
-3,105
| -11% | -$1.09M | 0.01% | 444 |
|
|
2023
Q2 | $10.4M | Buy |
29,451
+2,018
| +7% | +$680K | 0.01% | 448 |
|
|
2023
Q1 | $8.64M | Buy |
27,433
+1,364
| +5% | +$409K | 0.01% | 474 |
|
|
2022
Q4 | $7.53M | Buy |
26,069
+486
| +2% | +$148K | 0.01% | 489 |
|
|
2022
Q3 | $7.41M | Sell |
25,583
-670
| -3% | -$193K | 0.01% | 430 |
|
|
2022
Q2 | $7.4M | Buy |
26,253
+1,669
| +7% | +$447K | 0.01% | 381 |
|
|
2022
Q1 | $6.42M | Sell |
24,584
-687
| -3% | -$163K | ﹤0.01% | 425 |
|
|
2021
Q4 | $5.55M | Buy |
25,271
+1,157
| +5% | +$225K | ﹤0.01% | 448 |
|
|
2021
Q3 | $4.37M | Sell |
24,114
-899
| -4% | -$176K | ﹤0.01% | 446 |
|
|
2021
Q2 | $5.04M | Sell |
25,013
-1,040
| -4% | -$218K | ﹤0.01% | 431 |
|
|
2021
Q1 | $5.6M | Buy |
26,053
+1,226
| +5% | +$269K | ﹤0.01% | 418 |
|
|
2020
Q4 | $5.87M | Buy |
24,827
+353
| +1% | +$81K | ﹤0.01% | 401 |
|
|
2020
Q3 | $6.66M | Buy |
24,474
+1,151
| +5% | +$318K | 0.01% | 374 |
|
|
2020
Q2 | $6.77M | Sell |
23,323
-428
| -2% | -$116K | 0.01% | 365 |
|
|
2020
Q1 | $5.65M | Buy |
23,751
+1,398
| +6% | +$321K | 0.01% | 344 |
|
|
2019
Q4 | $4.89M | Buy |
22,353
+228
| +1% | +$46.1K | ﹤0.01% | 394 |
|
|
2019
Q3 | $3.75M | Buy |
22,125
+276
| +1% | +$48.8K | ﹤0.01% | 465 |
|
|
2019
Q2 | $4.01M | Buy |
21,849
+6,660
| +44% | +$1.16M | ﹤0.01% | 451 |
|
|
2019
Q1 | $2.79M | Buy |
15,189
+12,768
| +527% | +$2.36M | ﹤0.01% | 483 |
|
|
2018
Q4 | $401K | Buy |
2,421
+223
| +10% | +$38.6K | ﹤0.01% | 677 |
|
|
2018
Q3 | $424K | Buy |
+2,198
| New | +$391K | ﹤0.01% | 674 |
|
|
2018
Q1 | – | Sell |
-5,089
| Closed | -$763K | – | 828 |
|
|
2017
Q4 | $763K | Buy |
5,089
+105
| +2% | +$15.5K | ﹤0.01% | 606 |
|
|
2017
Q3 | $758K | Sell |
4,984
-962
| -16% | -$145K | ﹤0.01% | 589 |
|
|
2017
Q2 | $766K | Buy |
5,946
+733
| +14% | +$88.2K | ﹤0.01% | 563 |
|
|
2017
Q1 | $570K | Buy |
5,213
+45
| +0.9% | +$3.96K | ﹤0.01% | 549 |
|
|
2016
Q4 | $381K | Hold |
5,168
| – | – | ﹤0.01% | 596 |
|
|
2016
Q3 | $451K | Buy |
5,168
+56
| +1% | +$5.29K | ﹤0.01% | 581 |
|
|
2016
Q2 | $461K | Sell |
5,112
-43
| -0.8% | -$3.71K | ﹤0.01% | 568 |
|
|
2016
Q1 | $421K | Sell |
5,155
-388
| -7% | -$35.1K | ﹤0.01% | 580 |
|
|
2015
Q4 | $697K | Buy |
5,543
+615
| +12% | +$74.2K | ﹤0.01% | 542 |
|
|
2015
Q3 | $513K | Buy |
4,928
+550
| +13% | +$70.7K | ﹤0.01% | 549 |
|
|
2015
Q2 | $541K | Sell |
4,378
-8
| -0.2% | -$1.01K | ﹤0.01% | 447 |
|
|
2015
Q1 | $517K | Buy |
4,386
+8
| +0.2% | +$959 | ﹤0.01% | 442 |
|
|
2014
Q4 | $520K | Sell |
4,378
-215
| -5% | -$24.2K | ﹤0.01% | 448 |
|
|
2014
Q3 | $516K | Sell |
4,593
-2,160
| -32% | -$206K | ﹤0.01% | 433 |
|
|
2014
Q2 | $639K | Buy |
+6,753
| New | +$474K | ﹤0.01% | 416 |
|
Other funds holding VRTX
VCM
VPM
Ken Fisher's VRTX Position: Q1 2026 in Review
Ken Fisher increased its Vertex Pharmaceuticals (VRTX) stake by 24% in Q1 2026, buying an estimated $2.77M and bringing the position to 31,158 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #360.
Ken Fisher first reported a position in VRTX in Q2 2014 and has held it in 46 quarters since. The position peaked at $14.9M in Q1 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Ken Fisher held 31,158 shares of Vertex Pharmaceuticals worth $13.9M as of Q1 2026.
- Ken Fisher bought 5,940 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.77M.
- Vertex Pharmaceuticals made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #360 holding.
- Ken Fisher first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 46 quarters since.
- Ken Fisher's Vertex Pharmaceuticals position peaked at $14.9M in Q1 2025.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.